Kyoto, Japan

Kazuo Kariyone


Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Kyoto, JA (1977)
  • Kyoto, JP (1985 - 1986)

Company Filing History:


Years Active: 1977-1986

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kazuo Kariyone: Innovator in Animal Health

Introduction

Kazuo Kariyone is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of animal health through his innovative inventions. With a total of 3 patents, Kariyone has focused on developing solutions that enhance the well-being and growth of animals.

Latest Patents

Kariyone's latest patents include an antimycoplasmal agent for animals and a method of use for prevention. This invention relates to an antimycoplasmal agent designed for the prevention or treatment of mycoplasmosis in animals. It comprises an acyl peptide with specific chemical properties. Another significant patent is for an animal growth promotant and method of use for animal growth. This invention introduces a new animal growth promotant that includes an acyl peptide or its non-toxic salt as an active ingredient. It also outlines methods for promoting animal growth, improving weight gain rates, and enhancing feed utilization efficiency.

Career Highlights

Kariyone is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in advancing research and development in animal health products. His work has had a positive impact on the industry, contributing to better health outcomes for livestock.

Collaborations

Throughout his career, Kariyone has collaborated with esteemed colleagues such as Hirofumi Takagi and Kiyohiko Kunugita. These collaborations have fostered innovation and have been crucial in the development of his patented inventions.

Conclusion

Kazuo Kariyone's contributions to animal health through his patents demonstrate his commitment to improving the welfare of animals. His innovative solutions continue to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…